Minister Bruton welcomes the creation of 50 new jobs in Dublin at the Neuromod Clinic

12th December 2011

Neuromod launches new treatment device for Tinnitus called mutebutton™

Expansion project is supported by Dept of Jobs through Enterprise Ireland

The Minister for Jobs, Enterprise and Innovation Richard Bruton TD today announced that Neuromod will create an additional 50 jobs for Dublin over the coming years. The announcement came as Neuromod launched mutebutton™ a new device for the treatment of Tinnitus.  The announcement is as a result of research and development undertaken by Neuromod Devices.

At the Launch of Neuromod new device for the treatment of Tinnitus are Left to Right: Dr Ross O’Neill Founder and CEO of Neuromod Devices; Sarita Johnston, Enterprise Ireland and Minister for Jobs, Enterprise and Innovation Richard Bruton TD.

At the Launch of Neuromod new device for the treatment of Tinnitus are Left to Right: Dr Ross O’Neill Founder and CEO of Neuromod Devices; Sarita Johnston, Enterprise Ireland and Minister for Jobs, Enterprise and Innovation Richard Bruton TD.

Neuromod Devices plan to achieve the creation of 50 new jobs over the next 5 years in Dublin. These highly specialized roles will be key in supporting their global growth targets to become a leading global provider of non-surgical neuromodulation treatments for chronic conditions. This project has been supported by the Department of Jobs through Enterprise Ireland.

Mutebutton™ is an innovative, clinically proven, self-administered treatment designed to alleviate the symptoms of chronic tinnitus sufferers, mutebutton™ is the culmination of over four years of research and development since the company was first founded in 2010 by CEO, Dr. Ross O’Neill.

Minister Bruton said: "A key part of our Action Plan for Jobs is turning good ideas into good jobs. Over the past decade we have invested heavily in Government-supported research and innovation – the challenge we have been trying to address in the past three years is to build on that to create commercial ideas and ultimately jobs. Today Neuromod is announcing that it is creating an extra 50 high-end jobs in Dublin as a result of a product it has created through innovation it has carried out – this is a great example of what we are trying to achieve. I congratulate Neuromod on its achievements and with Ross and the team every success in the coming years”.

From Monday 15th of December, Irish Tinnitus suffers will be the first members of the public to be able to access the mutebutton™ treatment through the Irish website ( Once purchased the device will be delivered to The Neuromod Clinic™, where patients will be given an appointment to have the device configured to their needs by a qualified audiologist.  This new investment is in response to increased demand in the global medical device market for sophisticated and innovative medical devices.

10% of UK adults have tinnitus, according to the British Tinnitus Association, with one in ten going on to report severe effects on their quality of life including depression, anxiety, stress and sleep deprivation. Unlike some tinnitus treatments, which seek to mask tinnitus with other sounds, mutebutton™ has been developed to directly reduce tinnitus levels, in order to deliver lasting benefits. The mutebutton™ system combines synchronous audio and lingual (tongue) stimulation to promote patient neuroplasticity, effectively ‘retraining’ the brain. Used for a minimum of 30 minutes a day over a ten week period, the treatment has been clinically proven to reduce the sounds of tinnitus in studies conducted by NUI Maynooth and the Hermitage Medical Centre Dublin.

Dr. Ross O’Neill, Chief Executive Officer of Neuromod Devices Ltd said “I am delighted to announce the launch of a revolutionary new treatment for tinnitus sufferers, a condition which has lacked sufficient treatment to date despite affecting 1 in 10 of us. After four years of research and development, today Neuromod Devices is positioned to meet the unmet needs of tinnitus patients’ globally, with the launch of the mutebutton™ device. I am immensely proud of what we have achieved as a small Irish SME, in just 4 years and this is in no small part thanks to the state support we have received from Enterprise Ireland and the NDRC.”

Caroline Hamilton, Managing Director of The Neuromod Clinic added “In developing the mutebutton™ tinnitus treatment we have always been committed to ensuring the best patient outcomes, which is why I am delighted to also announce the opening of The Neuromod Clinic™. Our vision for the clinic is to establish a new center of excellence for tinnitus treatment in Ireland, going beyond pure medical device sales to offer outstanding end-to-end patient care and support

Michael Moriarity, at Enterprise Ireland said: “Enterprise Ireland’s strategy is to work in partnership with the Irish companies to support their plans for growth and help them win new business in global markets.  As an Irish success story, Enterprise Ireland looks forward to continuing to work closely with Neuromod Devices as they seek to establish the mutebutton™ system on the global market and look to expand into new treatments and research.  It will now be possible to deliver a new global standard of care for chronic tinnitus suffers and grow their international business to create employment in Ireland.”

Neuromod Devices is headquartered in NovaUCD, the Centre for New Ventures and Entrepreneurs at University College Dublin (UCD). The mutebutton™ device comes on sale from 15th December in Ireland ahead of a wider European launch commencing January 2015. For more product information please visit 


For more information contact:  Padraig Rushe, Neuromod Devices, t: +353 1 716 3641 or e:

Photos on request from Fennell Photography Dublin  Tel: 01-6689766


About Neuromod Devices:

Neuromod Devices was founded by Dr Ross O’Neill in 2010 as a spin-out from NUI Maynooth to develop innovative neuromodulation technologies for the treatment of unaddressed neurological conditions. The company has developed a stable platform technology for the rapid development and evaluation of innovative neuromodulatory interventions and is certified to the highest international technical medical standards. This core technology will form the basis for a pipeline of new products that address high-value market opportunities.  

mutebutton™ is a completely new approach to the treatment of tinnitus. Unlike other technologies, such as noise-maskers and sound therapies that only provide relief while using the device, mutebutton™ is a clinically proven tinnitus treatment that combines auditory and lingual (tongue) stimulation to drive real improvement in the patient's condition after use.     

Tinnitus, commonly referred to as ‘ringing-in-the-ears’, is the perception of sound in the absence of a corresponding external stimulus. Tinnitus is not a disease or a syndrome but rather a set of symptoms.